ROSENBERGER BRIAN (VP, Commercial) sold 2.5% of their position (6.41K shares) of ZYNERBA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $8.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/14/2023ACC: 0001062993-23-018021
Officer· VP, Commercial
Since Jan 2019
+15.79K
Net shares
Net buyer
$8.5K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
22.20K acquired · 6.41K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+22.20K
Price / share
—
Trade value
—
% of position
9.5%
9/12/2023
233.77K→255.97K
Common Stock
Direct
Shares
−6.41K
Price / share
$1.33
Trade value
$8.50K
% of position
2.5%
9/13/2023
255.97K→249.56K
Total
Net shares
+15.79K
Net value
-$8.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/12/2023 | A · Award | +22.20K | — | — | 9.5% | 233.77K | 255.97K |
| Common Stock Direct | 9/13/2023 | S · Sale | −6.41K | $1.33 | $8.50K | 2.5% | 255.97K | 249.56K |
| Total | +15.79K | -$8.50K | ||||||
Derivative Transactions0
No derivative transactions reported